Get Drug targeting : organ-specific strategies PDF

By Meijer, D. K. F.; Molema, Grietje

ISBN-10: 3527299882

ISBN-13: 9783527299881

ISBN-10: 3527299890

ISBN-13: 9783527299898

ISBN-10: 3527301976

ISBN-13: 9783527301973

ISBN-10: 3527304274

ISBN-13: 9783527304271

ISBN-10: 3527304312

ISBN-13: 9783527304318

ISBN-10: 3527304568

ISBN-13: 9783527304561

ISBN-10: 3527304657

ISBN-13: 9783527304653

ISBN-10: 3527305211

ISBN-13: 9783527305216

ISBN-10: 3527306781

ISBN-13: 9783527306787

Show description

Read Online or Download Drug targeting : organ-specific strategies PDF

Best general & reference books

New PDF release: Introduction to Concepts and Theories in Physical Science

The outline for this ebook, creation to suggestions and Theories in actual technological know-how, can be drawing close.

New PDF release: Black powder manufacturing, testing & optimizing

Black Powder production, trying out & Optimizing - by means of Ian von Maltitz. Examines black powder making from basic combined parts to complex, professional-type creation. Describes all parts and techniques. From chemistry to physics, from mechanical to mystical, together with examining components, reading options and approaches, from affordable to the easiest.

Download e-book for iPad: Modern Drying Technology: Computational Tools at Different by Evangelos Tsotsas, Arun S. Mujumdar

Content material: bankruptcy 1 complete Drying types in keeping with quantity Averaging: history, software and point of view (pages 1–55): Prof. Patrick Perree, Dr. Romain Remond and Prof. Ian W. TurnerChapter 2 Pore? community types: a strong instrument to review Drying on the Pore point and comprehend the effect of constitution on Drying Kinetics (pages 57–102): Thomas Metzger, Prof.

Extra resources for Drug targeting : organ-specific strategies

Sample text

Viable Intellectual Property (IP) strategies ensure that invention-based research and development investments are protected. Strong IP protection is essential for the preservation and growth of a research-based enterprise, and thus for the sustained development of new and better medicines. Competition among research-based pharmaceutical companies is continually increasing. One company’s patent on a specific drug does not preclude other innovator companies from producing rival medicines to treat the same disease.

Growth is given relative to sales in 2000 [4]. Brand name Ingredient Company Indication targets Sales (growth) [$ million] Nexium® Esomeprazole AstraZenec ulcers proton pump inhibitor 623 (999%) Protonix® Pantoprazole Altana/Wyeth ulcers proton pump inhibitor 695 (426%) Advair® Albuterol & Fluticasone GlaxoSmithKline β2 agonist & corticosteroid asthma 1103 (351%) Remicade® Infliximab J&J/Schering-Pl. 5 billion in 2001, thus claiming a market share of 6%. 9 billion). 7 billion. It is interesting to note that four classes grew more than 20% in 2001, namely the cholesterol reducers (22%), the antipsychotics (30%), the oral antidiabetics (30%), and the antihistamines (22%) [4].

The Tufts University Centre for the Study of Drug Development found that the time from synthesis of a new drug to US marketing approval has increased dramatically [6]. 2). Lengthening development times dramatically increase the costs of bringing a new drug to market by increasing the capital needed for research and development activities. 2 Analysis of research and development timelines in recent years [6]. The preclinical research, clinical development, and approval times are explicitly given.

Download PDF sample

Drug targeting : organ-specific strategies by Meijer, D. K. F.; Molema, Grietje

by Edward

Rated 4.28 of 5 – based on 7 votes